bromodeoxyuridine has been researched along with Dermatitis Medicamentosa in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiken, M; Glatstein, E; Hsu, SM; Kinsella, TJ; Mitchell, JB; Morstyn, G; Rowland, J; Russo, A | 1 |
| Greinert, U; Müller-Quernheim, J; Schlaak, M; Schreiber, J; Zissel, G | 1 |
| Breathnach, SM; Fine, JD | 1 |
3 other study(ies) available for bromodeoxyuridine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
Topics: Bone Marrow; Bromodeoxyuridine; Drug Eruptions; Drug Evaluation; Glioblastoma; Humans; Infusions, Parenteral; Neoplasms; Radiation-Sensitizing Agents; Thrombocytopenia; Time Factors | 1984 |
Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Antitubercular Agents; Bromodeoxyuridine; Cells, Cultured; Chemical and Drug Induced Liver Injury; DNA Replication; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Diseases; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nervous System Diseases; Rifampin; Tuberculosis | 1999 |
Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy.
Topics: Brain Neoplasms; Bromodeoxyuridine; Dermatitis, Exfoliative; Drug Eruptions; Glioblastoma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Skin | 1986 |